In serous ovarian cancer (SOC), SALL4 has been shown to be frequently co-expressed with the ALDH1A1 marker, and high co-expression of these two proteins is significantly associated with advanced disease stage, metastasis and poorer prognosis. The gene discussed is SALL4; the disease is ovarian serous adenocarcinoma.